Stage III Lung Small Cell Carcinoma, by American Joint Committee on Cancer (AJCC) v7
1 clinical trials · Condition
◉ Watch Stage III Lung Small Cell Carcinoma, by American Joint Committee on Cancer (AJCC) v7
| Record | Firm | Date |
|---|---|---|
| Navitoclax and Vistusertib in Treating Patients With Relapsed Small Cell Lung Cancer and Other Solid Tumors (NCT03366103) | National Cancer Institute (NCI) | 2018-03-20 |
Track Stage III Lung Small Cell Carcinoma, by American Joint Committee on Cancer (AJCC) v7 automatically
Every clearance here is in the API, with alerts when new ones post.